Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May 26;13(6):106.
doi: 10.3390/ph13060106.

Animal Models of Metabolic Epilepsy and Epilepsy Associated Metabolic Dysfunction: A Systematic Review

Uday Praful Kundap  1   2 , Yam Nath Paudel  1 , Mohd Farooq Shaikh  1
Affiliations
Review

Animal Models of Metabolic Epilepsy and Epilepsy Associated Metabolic Dysfunction: A Systematic Review

Uday Praful Kundap et al. Pharmaceuticals (Basel). .

Abstract

Epilepsy is a serious neurological disorder affecting around 70 million people globally and is characterized by spontaneous recurrent seizures. Recent evidence indicates that dysfunction in metabolic processes can lead to the alteration of neuronal and network excitability, thereby contributing to epileptogenesis. Developing a suitable animal model that can recapitulate all the clinical phenotypes of human metabolic epilepsy (ME) is crucial yet challenging. The specific environment of many symptoms as well as the primary state of the applicable neurobiology, genetics, and lack of valid biomarkers/diagnostic tests are the key factors that hinder the process of developing a suitable animal model. The present systematic review summarizes the current state of available animal models of metabolic dysfunction associated with epileptic disorders. A systematic search was performed by using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) model. A range of electronic databases, including google scholar, Springer, PubMed, ScienceDirect, and Scopus, were scanned between January 2000 and April 2020. Based on the selection criteria, 23 eligible articles were chosen and are discussed in the current review. Critical analysis of the selected literature delineated several available approaches that have been modeled into metabolic epilepsy and pointed out several drawbacks associated with the currently available models. The result describes available models of metabolic dysfunction associated with epileptic disorder, such as mitochondrial respiration deficits, Lafora disease (LD) model-altered glycogen metabolism, causing epilepsy, glucose transporter 1 (GLUT1) deficiency, adiponectin responsive seizures, phospholipid dysfunction, glutaric aciduria, mitochondrial disorders, pyruvate dehydrogenase (PDH) α-subunit gene (PDHA1), pyridoxine dependent epilepsy (PDE), BCL2-associated agonist of cell death (BAD), Kcna1 knock out (KO), and long noncoding RNAs (lncRNA) cancer susceptibility candidate 2 (lncRNA CASC2). Finally, the review highlights certain focus areas that may increase the possibilities of developing more suitable animal models and underscores the importance of the rationalization of animal models and evaluation methods for studying ME. The review also suggests the pressing need of developing precise robust animal models and evaluation methods for investigating ME.

Keywords: animal model; metabolic epilepsy; metabolic genes; mitochondrial dysfunction; translational research.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Types of Metabolic Epilepsy.
Figure 2
Figure 2
Animal models of ME and epilepsy associated metabolic dysfunctions: This figure demonstrates the overall studies of animal model related to ME with different multi approach considered in the current review.
Figure 3
Figure 3
Study evaluation PRISMA flow chart for selection of articles.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Lin Lin Lee V., Kar Meng Choo B., Chung Y.-S., P Kundap U., Kumari Y., Shaikh M.F. Treatment, Therapy and Management of Metabolic Epilepsy: A Systematic Review. Int. J. Mol. Sci. 2018;19:871. doi: 10.3390/ijms19030871. - DOI - PMC - PubMed
    1. Kang H.-C., Lee Y.-M., Kim H.D. Mitochondrial disease and epilepsy. Brain Dev. 2013;35:757–761. doi: 10.1016/j.braindev.2013.01.006. - DOI - PubMed
    1. Pearson-Smith J., Patel M. Metabolic dysfunction and oxidative stress in epilepsy. Int. J. Mol. Sci. 2017;18:2365. doi: 10.3390/ijms18112365. - DOI - PMC - PubMed
    1. Berg A.T., Berkovic S.F., Brodie M.J., Buchhalter J., Cross J.H., van Emde Boas W., Engel J., French J., Glauser T.A., Mathern G.W. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia. 2010;51:676–685. doi: 10.1111/j.1528-1167.2010.02522.x. - DOI - PubMed
    1. Zempleni J., Hassan Y.I., Wijeratne S.S. Biotin and biotinidase deficiency. Expert Rev. Endocrinol. Metab. 2008;3:715–724. doi: 10.1586/17446651.3.6.715. - DOI - PMC - PubMed